세계의 말 헬스케어 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 적응증별, 활동별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Equine Healthcare Market Size, Share & Trends Analysis Report By Product, By Indication, By Activity (Sports/Racing, Recreation, Other Activities), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,302,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,698,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,488,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

말 헬스케어 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 말 헬스케어 시장 규모는 2030년까지 59억 1,000만 달러에 달했으며, 예측 기간 동안 CAGR은 8.32%를 나타낼 것으로 예측됩니다.

제품 연구개발 증가, 말용 진단제 수요, 주요 업계 관계자의 투자, 말 질병 유병률 증가는 시장 성장의 주요 요인 중 일부입니다. 예를 들어, 2021년 9월, 미국 농무부는 동물 영양·건강 분야에 약 30억 달러를 투자했습니다.

COVID-19의 대유행은 특히 경마/스포츠 부문에 현저한 영향을 미쳤습니다. 말 케어 서비스에 대한 액세스가 감소하고 승마 쇼가 중단되었습니다. COVID-19의 결과, 교육, 교육, 경쟁, 이벤트, 관광 관련 활동, 레크리에이션 활동이 모두 중단되었습니다. 경마는 승마 수요와 함께 세계에서 악영향을 받았습니다. EU 내에서 경마를 계속하고 있던 것은 스웨덴뿐이었습니다. 프랑스 말 산업 클러스터인 Hippolia가 실시한 조사에 따르면, 응답자의 68.8%가 부족한 회복이 불가능하다고 생각하고, 모든 마술 경기가 폐지되었습니다. 스포츠마의 손실은 추계로 총 3억 8,589만 달러에 달했습니다. 그러나 폐쇄 조치의 완화와 말 헬스케어에 대한 액세스 개선으로 2021년에는 시장이 회복되었습니다.

기술 진보, 연구 개발, 시장 진출기업에 의한 말 진단의 이니셔티브 증가는 시장을 견인하는 중요한 요소입니다. 예를 들어, 미국 수의사회(American Veterinary Medical Association)가 2022년 7월에 발표한 논문에 따르면, 임상적인 두경부 합병증을 가진 말의 영상 진단에 이용되는 독자적인 헬리컬 팬 빔 기반 CT의 진단 성능을 평가하는 연구가 실시되었습니다. 총 120마리 이상의 말이 대상이 되었고, 두 대학 병원에서 두경부 CT 스캔을 받은 말의 차트가 조사되었습니다. 연령, 성별, 견종, 주소, 진정제 사용량, 수술 시간, 추가 영상 진단 기술 사용, 영상 진단, 임상 진단 및 영상 진단과 관련된 모든 문제가 기록되었습니다. CT 시스템은 스캔 시간이 짧고 말의 치아와 부비동의 정기적 인 촬영에 신뢰할 수 있는 유용성이 있음이 입증되었습니다.

또한 말의 질병 유행이 증가하고 있는 것도 시장 성장을 가속하는 요인 중 하나입니다. 예를 들어, 웨스트나일 바이러스는 2022년 9월 캘리포니아주 식품농업국에 의해 일시적인 발열과 신경증상을 보였던 네바다 카운티의 10세의 백신 미접종 쿼터호스 종마에서 양성으로 확인되었습니다. 했습니다. 이는 2022년 캘리포니아에서 확인된 8번째 말 WNV 사례였습니다. 기타, 컨주 3례, 네바다주 1례, 새크라멘토주 1례, 샌루이스 오비스포주 1례, 테하마주 1례, 툴레어 주 3례의 총 6군에서 양성 예가 확인되었습니다. 이로 인해 말의 질병에 대한 인식이 퍼지면서 말에 적시에 예방 접종에 대한 수요가 높아질 것으로 기대됩니다.

말 헬스케어 시장 보고서 하이라이트

• 제품별로는 의약품이 2023년에 25.96% 이상의 점유율을 차지하고 시장을 독점했습니다.
• 재생 의료 및 줄기 세포 치료 솔루션으로 구성된 다른 제품 부문은 예측 기간 동안 가장 빠르게 성장하는 부문으로 예측됩니다.
• 적응증별로는 기생충 감염증 분야가 2023년에 26.56% 초과의 최대 점유율을 차지했습니다. 이는 내부 및 외부 기생충을 치료하는 효과적인 기생충 치료제에 대한 수요 증가로 인한 것입니다.
• 스포츠/레이스 활동 분야는 2023년 56.38% 이상의 수익 점유율로 시장을 독점하고 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예측됩니다.
• 유통 채널별로 동물병원 및 진료소가 2023년에 가장 큰 점유율을 차지했습니다. 전자상거래 분야는 예측 기간 동안 가장 빠른 CAGR로 확대될 것으로 예측됩니다.
• 북미와 유럽은 2023년에 주목할만한 점유율을 차지했습니다. 아시아태평양은 승마 경주/스포츠 분야에서 싹트기 때문에 예측 기간에 유리한 성장을 보여줄 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 말 헬스케어 시장의 변동 동향과 범위

• 시장 계통 전망
• 시장 역학
• 말 헬스케어 시장 분석 도구

제4장 말 헬스케어 시장 : 제품 추정·동향 분석

• 부문 대시보드
• 말 헬스케어 시장 제품 변동 분석
• 말 헬스케어 시장 규모와 동향 분석, 제품별, 2018-2030년

제5장 말 헬스케어 시장 : 적응증의 추정·동향 분석

• 부문 대시보드
• 말 헬스케어 시장의 변동 분석
• 말 헬스케어 시장 규모와 동향 분석, 적응증, 2018-2030년

제6장 말 헬스케어 시장 : 활동 추정·동향 분석

• 부문 대시보드
• 말 헬스케어 시장의 변동 분석
• 말 헬스케어 시장 규모와 동향 분석, 활동 유형, 2018-2030년

제7장 말 헬스케어 시장 : 유통 채널별 추정·동향 분석

• 부문 대시보드
• 말 헬스케어 시장의 변동 분석
• 말 헬스케어 시장 규모와 동향 분석, 유통 채널별, 2018-2030년

제8장 말 헬스케어 시장 : 국가 추정·동향 분석, 제품, 적응증, 활동, 유통 채널별

• 지역 대시보드
• 말 헬스케어 시장 점유율, 지역별, 2023년 및 2030년
• 지역 전망
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 구도

• 시장 진출기업의 분류
• Participants Overview
• 재무실적
• 제품 벤치마킹
• 시장 포지셔닝 분석, 2023년(히트 맵 분석)
• 전략 매핑
  • 합병과 인수
  • 발사
  • 파트너십과 협업
  • 확대
  • 기타
• 기업 프로파일
  • Zoetis
  • Arthrex Inc.
  • Dechra Pharmaceuticals
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska Corporation
  • Merck &Co Inc.
  • Esaote SpA
  • IDEXX Laboratories Inc.
  • Covetrus Inc.
  • Elanco
  • Cargill
• 기타 주요 시장 기업 목록

제10장 중요한 포인트

JHS

영문 목차

영문목차

Equine Healthcare Market Growth & Trends:

The global equine healthcare market size is expected to reach USD 5.91 billion by 2030, registering a CAGR of 8.32% during the forecast period, according to a new report by Grand View Research, Inc. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

Equine Healthcare Market Report Highlights:

• Based on product, the pharmaceuticals segment dominated the market with a share of over 25.96% in 2023 owing to a high uptake and wide availability of these products
• The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period
• Based on indication, parasite infections segment held the largest share of over 26.56% in 2023. It is due to the growing demand for effective parasiticides for the control of internal and external parasites
• The sports/racing activity segment dominated the market with a revenue share of over 56.38% in 2023 and is anticipated to grow at the fastest rate during the forecast period
• Based on distribution channel, veterinary hospitals and clinics held the largest share in 2023. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period
• North America and Europe held notable shares in 2023. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Equine Healthcare Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Include Growing R&D Initiatives,
    • 3.2.1.2. Rise In Equine Health Complications,
    • 3.2.1.3. Rising Popularity Of Equine-Assisted Therapy
    • 3.2.1.4. Emergence Of Artificial Intelligence (AI) In Equine Health
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Expenditure
    • 3.2.2.2. Availability of Substitutes
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Equine Healthcare Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Horse Population, by Key Countries, 2018 - 2023
  • 3.3.5. Pricing Analysis
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Equine Healthcare Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Equine Healthcare Market Product Movement Analysis
• 4.3. Equine Healthcare Market Size & Trend Analysis, By Product, 2018-2030 (USD Million)
  • 4.3.1. Vaccines
    • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.2. Pharmaceuticals
    • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.2. Parasiticides
    • 4.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.3. Anti-infectives
    • 4.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.4. Anti-inflammatory & Analgesics
    • 4.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.5. Other Pharmaceuticals
    • 4.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.3. Medicinal Feed Additives
    • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.4. Orthobiologics
    • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.5. Diagnostics
    • 4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.5.2. Diagnostic Test Kits
    • 4.3.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.5.3. Diagnostic Equipment
    • 4.3.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.6. Software & Services
    • 4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.2. Practice Management Software
    • 4.3.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.3. Imaging Software
    • 4.3.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.4. Telehealth Software
    • 4.3.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.5. Other Software
    • 4.3.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.7. Other Products
    • 4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Equine Healthcare Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Equine Healthcare Market Movement Analysis
• 5.3. Equine Healthcare Market Size & Trend Analysis, Indication, 2018-2030 (USD Million)
  • 5.3.1. Musculoskeletal Disorders
    • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Parasitic Infections
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Equine Herpes Virus
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Equine Viral Arteritis (EVA)
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. Equine Influenza
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.6. West Nile Virus
    • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.7. Tetanus
    • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.8. Other Indications
    • 5.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Equine Healthcare Market: By Activity Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Equine Healthcare Market Movement Analysis
• 6.3. Equine Healthcare Market Size & Trend Analysis, Activity type, 2018-2030 (USD Million)
  • 6.3.1. Sports/Racing
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Recreation
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Other Activities
    • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Equine Healthcare Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Equine Healthcare Market Movement Analysis
• 7.3. Equine Healthcare Market Size & Trend Analysis, By Distribution Channel, 2018-2030 (USD Million)
  • 7.3.1. Veterinary Hospitals & Clinics
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. E-commerce
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Equestrian Facilities
    • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Other Channels
    • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Equine Healthcare Market: Country Estimates & Trend Analysis, by Product, Indication, Activity & Distribution Channel

• 8.1. Regional Dashboard
• 8.2. Equine Healthcare Market Share, By Region, 2023 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competition Insights
    • 8.4.2.3. U.S. Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competition Insights
    • 8.4.3.3. Canada Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competition Insights
    • 8.4.4.3. Mexico Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competition Insights
    • 8.5.2.3. UK Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competition Insights
    • 8.5.3.3. Germany Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competition Insights
    • 8.5.4.3. France Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competition Insights
    • 8.5.5.3. Italy Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competition Insights
    • 8.5.6.3. Spain Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competition Insights
    • 8.5.7.3. Denmark Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competition Insights
    • 8.5.8.3. Sweden Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competition Insights
    • 8.5.9.3. Norway Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Netherlands
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competition Insights
    • 8.5.10.3. Netherlands Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Russia
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competition Insights
    • 8.5.11.3. Russia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.12. Switzerland
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competition Insights
    • 8.5.12.3. Switzerland Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competition Insights
    • 8.6.2.3. Japan Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competition Insights
    • 8.6.3.3. China Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competition Insights
    • 8.6.4.3. India Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competition Insights
    • 8.6.5.3. Australia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competition Insights
    • 8.6.6.3. South Korea Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competition Insights
    • 8.6.7.3. Thailand Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competition Insights
    • 8.7.2.3. Brazil Equine Healthcare Market Estimates And Forecasts, 2018 - 2030
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competition Insights
    • 8.7.3.3. Argentina Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competition Insights
    • 8.8.2.3. South Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competition Insights
    • 8.8.3.3. Saudi Arabia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competition Insights
    • 8.8.4.3. UAE Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competition Insights
    • 8.8.5.3. Kuwait Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Participants Overview
• 9.3. Financial Performance
• 9.4. Product Benchmarking
• 9.5. Market Position Analysis, 2023 (Heat Map Analysis)
• 9.6. Strategy Mapping
  • 9.6.1. Mergers And Acquisitions
  • 9.6.2. Launch
  • 9.6.3. Partnerships & Collaborations
  • 9.6.4. Expansion
  • 9.6.5. Others
• 9.7. Company Profiles
  • 9.7.1. Zoetis
    • 9.7.1.1. Participant's overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. Product benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. Arthrex Inc.
    • 9.7.2.1. Participant's overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. Product benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. Dechra Pharmaceuticals
    • 9.7.3.1. Participant's overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. Product benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Boehringer Ingelheim
    • 9.7.4.1. Participant's overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. Product benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Ceva Sante Animale
    • 9.7.5.1. Participant's overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. Product benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. Heska Corporation
    • 9.7.6.1. Participant's overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. Product benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. Merck & Co Inc.
    • 9.7.7.1. Participant's overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. Product benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. Esaote SpA
    • 9.7.8.1. Participant's overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. Product benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. IDEXX Laboratories Inc.
    • 9.7.9.1. Participant's overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. Product benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. Covetrus Inc.
    • 9.7.10.1. Participant's overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. Product benchmarking
    • 9.7.10.4. Strategic initiatives
  • 9.7.11. Elanco
    • 9.7.11.1. Participant's overview
    • 9.7.11.2. Financial performance
    • 9.7.11.3. Product benchmarking
    • 9.7.11.4. Strategic initiatives
  • 9.7.12. Cargill
    • 9.7.12.1. Participant's overview
    • 9.7.12.2. Financial performance
    • 9.7.12.3. Product benchmarking
    • 9.7.12.4. Strategic initiatives
• 9.8. List of Other Key Market Players

Chapter 10. Key Takeaways

관련자료